TOP CLASS HEALTHCARE, FI
Cartera
Este fondo se corresponde con los siguientes códigos ISIN: ES0179362001
| Patrimonio | 5.195.593€ |
|---|---|
| Partícipes | 245 |
| Patrimonio por partícipe | 21.206,50€ |
Cartera del fondo a 2018-12-31
El fondo invierte en 69 activos diferentes:
| Activo | ISIN | Porcentaje |
|---|---|---|
| ROCHE HOLDG | CH0012032048 | 4,92% |
| MERCK & CO. | US58933Y1055 | 4,17% |
| JOHNSON & JOHNSON S | US4781601046 | 3,97% |
| BAYER AG | DE000BAY0017 | 3,44% |
| HCA HOLDINGS INC | US40412C1018 | 3,33% |
| PFIZER INC. | US7170811035 | 3,12% |
| GILEAD SCIENCES | US3755581036 | 2,98% |
| STRYKER CORP | US8636671013 | 2,80% |
| UNITEDHEALTH GROUP | US91324P1021 | 2,72% |
| MEDTRONIC PLC | IE00BTN1Y115 | 2,71% |
| AMGEN INC. | US0311621009 | 2,70% |
| ANTHEM INC | US0367521038 | 2,60% |
| ABBVIE INC | US00287Y1091 | 2,01% |
| CELGENE CORP | US1510201049 | 1,97% |
| BRISTOL-MYERS | US1101221083 | 1,91% |
| CIGNA CORP NUEVAS | US1255231003 | 1,88% |
| ESTEE LAUDER COMPANIES | US5184391044 | 1,81% |
| BIOGEN IDEC INC | US09062X1037 | 1,79% |
| DANAHER CORP | US2358511028 | 1,64% |
| ISHARES NASDAQ BIOTECH INDX | US4642875565 | 1,63% |
| MYLAN NV -- NASDAQ | NL0011031208 | 1,63% |
| RAMSAY HEALTH CARE LTD | AU000000RHC8 | 1,61% |
| THERMO FISHER SCIENTIFIC INC | US8835561023 | 1,55% |
| ZIMMER BIOMET HOLDINGS INC | US98956P1021 | 1,54% |
| REGENERON PHARMACEUTICALS | US75886F1075 | 1,48% |
| ALEXION PHARMACEUTICALS INC | US0153511094 | 1,45% |
| BOSTON SCIENTIFIC CORP | US1011371077 | 1,40% |
| ELI LILLY & CO | US5324571083 | 1,38% |
| COTY INC -CL A | US2220702037 | 1,30% |
| ESTIA HEALTH LTD | AU000000EHE2 | 1,28% |
| NU SKIN ENTERPRISES INC - A | US67018T1051 | 1,22% |
| JAZZ PHARMACEUTICALS PLC | IE00B4Q5ZN47 | 1,17% |
| USANA HEALTH SCIENCES INC | US90328M1071 | 1,17% |
| UNIVERSAL HEALTH SEVICES-B | US9139031002 | 1,16% |
| NOVO-NORDISK A/S-SPONS ADR | US6701002056 | 1,14% |
| FIRST TRUST NYSE ARCA BIOTEC ETF | US33733E2037 | 1,11% |
| DENTSPLY SIRONA INC | US24906P1093 | 1,11% |
| MCKESSON CORP | US58155Q1031 | 1,10% |
| INCYTE GENOMICS | US45337C1027 | 1,07% |
| ALLSCRIPTS HEALTHCARE SOLUTIONS | US01988P1084 | 1,05% |
| SANOFI | FR0000120578 | 1,03% |
| MERCK KGAA | DE0006599905 | 1,02% |
| HEALIUS LTD | AU0000033359 | 0,94% |
| CENTENE CORPORATION | US15135B1017 | 0,91% |
| ANI PHARMACEUTICALS INC | US00182C1036 | 0,89% |
| NOVARTIS AG-ADR | US66987V1098 | 0,85% |
| NOVARTIS AG REG.SHS. | CH0012005267 | 0,85% |
| ALLERGAN PLC -- NYSE | IE00BY9D5467 | 0,85% |
| GRIFOLS SA-ADR | US3984384087 | 0,80% |
| HORIZON PHARMA PLC | IE00BQPVQZ61 | 0,78% |
| CHINA BIOLOGIC PRODUCTS INC | KYG215151047 | 0,75% |
| BELLAMYS AUSTRALIA LTD | AU000000BAL8 | 0,72% |
| ARENA PHARMACEUTICALS INC | US0400476075 | 0,62% |
| INTERCEPT PHARMACEUTICALS IN | US45845P1084 | 0,60% |
| ARRAY BIOPHARMA INC | US04269X1054 | 0,51% |
| COHERUS BIOSCIENCES INC | US19249H1032 | 0,50% |
| GENMAB A/S -SP ADR | US3723032062 | 0,49% |
| REVANCE THERAPEUTICS INC | US7613301099 | 0,48% |
| ACADIA PHARMACEUTICALS INC | US0042251084 | 0,45% |
| BLUEBIRD BIO | US09609G1004 | 0,44% |
| INTRA-CELLULAR THERAPIES | US46116X1019 | 0,41% |
| SERES THERAPEUTICS | US81750R1023 | 0,40% |
| IRONWOOD PHARMACEUTICALS INC | US46333X1081 | 0,39% |
| INTELLIA THERAPEUTICS | US45826J1051 | 0,38% |
| SYNDAX PHARMACEUTICALS INC | US87164F1057 | 0,35% |
| PROTAGONIST THERAPEUTICS | US74366E1029 | 0,35% |
| BELLICUM PHARMACEUTICALS INC | US0794811077 | 0,32% |
| CELLDEX THERAPEUTICS INC | US15117B1035 | 0,27% |
| NEWLINK GENETICS CORP | US6515111077 | 0,27% |
Tenga en cuenta que el informe de cartera del fondo hace referencia a cierre del mercado del día y en ningún caso los activos que aparecen aquí están ponderados durante las sesiones del trimestre anterior
TOP CLASS HEALTHCARE, FI
Fondo de inversión armonizado gestionado por RENTA 4 GESTORA, S.G.I.I.C., S.A.
5,2M
patrimonio
245
partícipes
6, en una escala de 1 al 7
perfil de riesgo